Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News North European Oil Royalty Trust NRT

Energy Oil & Gas E&P
North European Oil Royalty Trust (the Trust) is a grantor trust which, on behalf of the owners of units of beneficial interest in the Trust (the unit owners), holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The rights are held under contracts with local German exploration and development subsidiaries of... see more

Recent & Breaking News (NYSE:NRT)

North European Oil Royalty Trust Announces Net Income And Results For The Third Quarter Of Fiscal 2014

PR Newswire August 13, 2014

Novogen Announces Results of General Meeting of Shareholders

PR Newswire August 13, 2014

Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy

PR Newswire August 12, 2014

North European Oil Royalty Trust Announces The Distribution For The Third Quarter Of Fiscal 2014

PR Newswire July 31, 2014

Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil(TM)

PR Newswire July 25, 2014

Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem Cells

PR Newswire June 17, 2014

Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer

PR Newswire May 27, 2014

North European Oil Royalty Trust Announces Net Income And Results For The Second Quarter Of Fiscal 2014

PR Newswire May 14, 2014

Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood Cancers

PR Newswire May 4, 2014

Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative Diseases

PR Newswire May 2, 2014

North European Oil Royalty Trust Announces The Distribution For The Second Quarter Of Fiscal 2014

PR Newswire April 30, 2014

Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo

PR Newswire March 18, 2014

Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York

PR Newswire March 12, 2014

Novogen Selected to Present at Cavendish Global Health Impact Forum

PR Newswire March 10, 2014

Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical Development and Growing International Presence

PR Newswire March 4, 2014

North European Oil Royalty Trust Announces Net Income And Results For The First Quarter Of Fiscal 2014

PR Newswire February 14, 2014

Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform

PR Newswire February 3, 2014

North European Oil Royalty Trust Announces The Distribution For The First Quarter Of Fiscal 2014

PR Newswire January 31, 2014

Novogen to Host Corporate Update and Webcast

PR Newswire January 30, 2014

Novogen to Present at Biotech Showcase(TM) 2014

PR Newswire January 8, 2014